Sonoma Pharmaceuticals (SNOA) Income from Discontinued Operations (2016 - 2021)
Sonoma Pharmaceuticals (SNOA) posted quarterly Income from Discontinued Operations of 228000.0 for Q1 2021, up 147.83% year-over-year from 92000.0 in Q1 2020, and up 147.83% quarter-over-quarter from 92000.0 in Q1 2020.
Sonoma Pharmaceuticals (SNOA) Income from Discontinued Operations (2016 - 2021) Analysis & Trends
Sonoma Pharmaceuticals' Income from Discontinued Operations history runs 4 years deep, the most recent figure standing at 228000.0 for Q1 2021.
- In Q1 2021, Income from Discontinued Operations rose 147.83% year-over-year to 228000.0; the TTM figure through Sep 2021 stood at 228000.0 (up 147.83% YoY), while the FY2021 annual figure was 228000.0, up 147.83% from the prior year.
- Income from Discontinued Operations for Q1 2021 stood at 228000.0, up from 92000.0 in the prior quarter.
- The five-year high for Income from Discontinued Operations was 228000.0 in Q1 2021, with the low at 301000.0 in Q1 2017.
- The 3-year median for Income from Discontinued Operations is 92000.0 (2020), against an average of 6333.33.
- Peak annual rise in Income from Discontinued Operations reached 147.83% in 2021, while the deepest fall reached 147.83% in 2021.
- Sonoma Pharmaceuticals' Income from Discontinued Operations stood at 301000.0 in 2017, then surged by 130.56% to 92000.0 in 2020, then soared by 147.83% to 228000.0 in 2021.
- Business Quant data shows SNOA's Income from Discontinued Operations at 228000.0 in Q1 2021, 92000.0 in Q1 2020, and 301000.0 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.19 Mn | -145,899.91 | 2.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 228,000.00 |
| Mar 31, 2020 | 92,000.00 |
| Mar 31, 2017 | -301,000.00 |
| Dec 31, 2016 | 4.58 Mn |
| Sep 30, 2016 | 1.05 Mn |
| Jun 30, 2016 | 319,000.00 |